Lichen nitidus treatment market to reach $2.91 billion by 2030 at 7.4% CAGR, driven by significant growth in chemical exposure and rising prevalence of skin infections.
Read More
Levofloxacin market to reach $2.42 billion by 2030 at 5.9% CAGR, driven by rising number of bacterial infections and increasing healthcare expenditure.
Read More
Leuprorelin drugs market to reach $3.95 billion by 2030 at 6.5% CAGR, driven by increasing prevalence of prostate cancer and rising demand for ivf treatments.
Read More
Leuprolide acetate market to reach $3.71 billion by 2030 at 6.4% CAGR, driven by increasing prevalence of prostate cancer.
Read More
Leukotriene modifiers market to reach $30.63 billion by 2030 at 5.3% CAGR, driven by increasing incidence of asthma and allergic conditions.
Read More
Leukemia therapeutics market to reach $27.41 billion by 2030 at 8.0% CAGR, driven by rising prevalence of leukemia.
Read More
Leukemia inhibitory factor (lif) market to reach $1.37 billion by 2030 at 8.2% CAGR, driven by increasing number of clinical trials and rising healthcare expenditure.
Read More
The global leukapheresis market to reach $104.27 billion by 2030 at 7.6% CAGR, driven by rise of autoimmune diseases.
Read More
Lentiviral vector market to reach $30.66 billion by 2030 at 12.8% CAGR, driven by increasing prevalence of chronic diseases.
Read More
Lennox gastaut syndrome market to reach $1.04 billion by 2030 at 6.9% CAGR, driven by increasing incidences of brain abnormalities.
Read More